Asia Pacific Mice Model Market (2025-2030)
The Asia Pacific Mice Model Market was valued at $9.67 Million in 2025 and projected to reach to $12.57 Million by 2030, representing a compound annual growth rate of 5.4%. The Asia Pacific mice model market is positioned for steady growth, driven by increasing pharmaceutical R&D investments across China, Japan, and India.
Asia Pacific Mice Model Market Trends and Insights
- In the Middle East, the mice model market is driven by increasing investment in biomedical research and pharmaceutical development across the region's emerging healthcare infrastructure.
- The Middle East's growing focus on precision medicine and drug discovery initiatives is positioning the region as an emerging hub for preclinical research activities. During the 2025–2030 forecast period, the Middle East mice model market will benefit from enhanced regulatory frameworks and collaborative research partnerships with global institutions.
- The Middle East is witnessing rising demand for standardized laboratory animal models as academic and commercial research organizations expand their capabilities.
- By 2030, the Middle East is expected to solidify its position in the global preclinical research landscape through sustained investment in research facilities and biotechnology infrastructure..
Key Market Statistics
- CAGR (2025-2030) 5.4% CAGR
- Market Size, 2025 ~USD 9.67 Million
- Forecast, 2030 ~USD 12.57 Million
- Geography Asia Pacific
Asia Pacific Mice Model Market Overview
China's Research Leadership :
China dominates the Asia Pacific mice model market with $183.7 million in market size, driven by rapid expansion of pharmaceutical R&D centers and government investment in life sciences infrastructure across major biotech hubs.
Japan's Advanced Biomedical Sector :
Japan represents the second-largest market at $119.3 million, leveraging its established pharmaceutical industry and cutting-edge research institutions to drive demand for high-quality laboratory mice models.
India's Emerging Growth Potential :
India's mice model market valued at $37 million is experiencing accelerated growth as contract research organizations expand and domestic pharmaceutical companies increase investment in preclinical testing capabilities.
Regional CAGR Outpacing Global Average :
Asia Pacific's 5.4% CAGR reflects strong momentum in emerging markets, with Australia ($38 million) and South Korea ($20.9 million) contributing to sustained regional expansion through 2030.
Asia Pacific Mice Model Market Dynamics
- The region's expanding contract research organization sector and rising adoption of personalized medicine approaches are accelerating demand for specialized mouse models.
- Government initiatives supporting biomedical research and the establishment of world-class research facilities are creating favorable conditions for market expansion. By 2030, Asia Pacific is expected to reach $12.57 million, reflecting growing recognition of mice models' critical role in drug development and disease research.
- China's continued dominance, coupled with emerging opportunities in India and Southeast Asia, positions the region as a key growth engine.
- Increasing collaboration between academic institutions and pharmaceutical companies will further drive market penetration and innovation in laboratory mouse breeding and supply..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The Middle East mice model market is valued at $9.67 million in 2025 and will reach $12.57 million by 2030.
- The Middle East market is growing at a 5.4% CAGR, driven by increased biomedical research investment and pharmaceutical development.
- The Middle East is emerging as a preclinical research hub supported by regulatory improvements and international research collaborations.
- The Middle East's focus on precision medicine and drug discovery is accelerating demand for standardized laboratory animal models.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
Asia Pacific Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : Evaluate Asia Pacific expansion opportunities and assess regional demand for mice models to support drug development pipelines and preclinical research operations.
- Contract Research Organizations : Understand market sizing and growth potential to guide investment in laboratory facilities, breeding capabilities, and service offerings across high-growth Asia Pacific markets.
- Biotech & Life Sciences Investors : Assess regional market dynamics and growth forecasts to identify investment opportunities in mice model suppliers, research infrastructure, and related biomedical services.
- Academic & Research Institutions : Benchmark regional research spending trends and identify funding opportunities to support preclinical research programs and laboratory animal model procurement strategies.
- Laboratory Animal Suppliers : Analyze country-specific demand patterns and market growth rates to optimize breeding operations, distribution networks, and product development for Asia Pacific customers.
Key Companies in the Asia Pacific Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 183.7 Million |
| Japan | USD 119.3 Million |
| India | USD 37 Million |
| Australia | USD 38 Million |
| South Korea | USD 20.9 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Insights : Access detailed market sizing for China ($183.7M), Japan ($119.3M), India ($37M), Australia ($38M), and South Korea ($20.9M) to identify high-potential investment and expansion opportunities.
- Growth Trajectory Analysis : Understand the 5.4% CAGR trajectory through 2030 with forecasts enabling strategic planning for supply chain development, facility expansion, and market entry strategies across Asia Pacific.
- Competitive Landscape Mapping : Benchmark your position against regional competitors and identify market gaps in emerging economies where pharmaceutical R&D investment is accelerating fastest.
- Regulatory & Infrastructure Assessment : Gain insights into biomedical research infrastructure development, government support mechanisms, and regulatory frameworks driving market adoption across key Asia Pacific nations.
- Strategic Partnership Opportunities : Identify collaboration potential with contract research organizations, academic institutions, and pharmaceutical companies expanding preclinical research capabilities throughout the region.
Frequently asked questions
What is the current size of the Middle East mice model market?
The Middle East mice model market is valued at $9.67 million in 2025.
What is the projected market size for the Middle East by 2030?
The Middle East mice model market is projected to reach $12.57 million by 2030.
What is the growth rate of the Middle East mice model market?
The Middle East mice model market is growing at a compound annual growth rate of 5.4% from 2025 to 2030.
What factors are driving growth in the Middle East mice model market?
Growth in the Middle East is driven by increased biomedical research investment, pharmaceutical development initiatives, precision medicine focus, and enhanced regulatory frameworks supporting preclinical research.
Why is the Middle East becoming important for mice model research?
The Middle East is emerging as a preclinical research hub due to growing research infrastructure, international collaborations, and regional emphasis on drug discovery and biotechnology development.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report